New drug trial aims to strengthen aging bones
NCT ID NCT07473713
First seen Mar 28, 2026 · Last updated May 16, 2026 · Updated 9 times
Summary
This study tests whether veverimer, a drug that lowers acid levels in the body, can reduce bone breakdown in adults aged 50 and older with osteopenia (low bone density). Sixty participants will take either veverimer or a placebo daily or every other day for 8 weeks. Researchers will measure changes in bone resorption and formation, as well as safety, to find the best dose.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OSTEOPENIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Tufts Medical Center
RECRUITINGBoston, Massachusetts, 02111, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.